BioCrest Sci
End‑to‑End Antibody Development · Multi‑platform Customization · Transparent Science
Scientist‑to‑ScientistAntibody Customization Services
Select the service that matches your project needs. Each option leads to a dedicated service page with detailed workflows, timelines, and technical specifications.
Custom Monoclonal Antibody
3–6 monthsHigh‑specificity antibodies from a single clone. Ideal for diagnostic development, flow cytometry, IHC, and long‑term reproducibility.
Custom Polyclonal Antibody
2–4 monthsRapid generation of antibody populations recognizing multiple epitopes. Well‑suited for WB, ELISA, protein tracking, and exploratory studies.
Custom Recombinant Antibody
4–10 weeks (after sequence)Sequence‑defined, renewable antibodies with batch‑to‑batch consistency. Supports engineering, humanization, affinity maturation & scalable manufacturing.
Custom Nanobody (VHH)
3–5 monthsSingle‑domain antibody fragments with small size and high stability. Perfect for intracellular targeting, structural biology, CAR‑T, and biosensors.
Neutralizing Antibody
Function‑drivenFunctionally validated antibodies that block biological activity — viral entry, receptor‑ligand interaction, cytokine signaling, or enzymatic inhibition.
Comparison of Antibody Production Platforms
| Service Type | Main Advantages | Typical Timeline | Best‑Fit Applications |
|---|---|---|---|
| Polyclonal Antibody | Fast and broad epitope recognition | ~2–4 months | WB, ELISA, exploratory studies |
| Monoclonal Antibody | Specificity and reproducibility | ~3–6 months | Diagnostics, flow cytometry, IHC |
| Recombinant Antibody | Sequence‑defined renewable reagent | ~1–3 months after sequence | Therapeutic and engineered antibody research |
| Nanobody (VHH) | Small size and high stability | ~3–5 months | Imaging, intracellular targeting, CAR research |
| Neutralizing Antibody | Functional biological inhibition | Variable | Antiviral and blocking studies |
Antigen Types Supported
Recombinant proteins, peptides (including phosphorylated), membrane proteins, GPCRs, ion channels, viral/bacterial antigens, toxins, haptens, and more.
Our scientists assist with epitope selection, antigen design, and immunization optimization.
Screening & Validation Options
Customizable screening aligned with your intended application:
- ELISA / MSD binding
- Western blot
- Flow cytometry
- Immunofluorescence (IF/ICC)
- Immunohistochemistry (IHC)
- Neutralization assays
- SPR / BLI affinity
- Cell‑based functional assays
- Pair screening for sandwich ELISA